X

Stay Connected

Sign Up for Updates

 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

ICYMI: Survey highlights key barriers limiting number and scale of new approaches to paying for medicines

By Michelle Drozd  |    March 27, 2017
In recent years we have seen remarkable scientific breakthroughs in the discovery of new therapies to treat some of the most challenging diseases faced by patients. These groundbreaking medicines...   Read More

Putting Patients at the Center of the Clinical Pathways Debate

By Guest Contributor  |    August 19, 2015
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

The Future of Clinical Pathways

By Guest Contributor  |    August 5, 2015
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

New Study Examines Clinical Pathways: An Overview of Current Practices and Potential Implications for Patients, Payers, and Providers

By Kelsey Lang  |    July 28, 2015
As health care payers seek to transition to new, value-based payment models, clinical pathways are one strategy payers and providers are using in their efforts to contain costs and promote...   Read More

Focusing Payment and Delivery on Patients

By Allyson Funk  |    May 15, 2015
As the way we pay for and deliver health care in the United States evolves, we’ve talked about the importance of patient engagement in the process and ensuring that our system doesn’t treat patients...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates